Lack of Self-Exams Hampers Early Melanoma Identification
Of those surveyed in rural communities, 43 percent intended to perform self-exam but did not follow through.
Daily Oncology News
Increasing Vegetable Intake Does Not Slow Prostate Cancer
Behavioral intervention had no impact on time to progression among men with early-stage disease.
Optimal Nurse Staffing Levels at Ambulatory Oncology Care Centers: ONS Position Statement
Ambulatory oncology care settings include outpatient centers for chemotherapy infusion and the administration of radiation therapy.
Study Supports Standard-Dose RT in Chemoradiotherapy for Patients With Stage III Unresectable NSCLC
Long-term follow-up of the Radiation Therapy Oncology Group 0617 trial continues to support a 60-Gy radiation therapy dose as the standard of care.
No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.
Prostate Cancer Treatment Side Effects Worse With Prostatectomy
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
Drug Assessment Framework for Evaluation of Cancer Drugs
Researchers suggested several criteria for determining drug value in a survey given to participants for feedback.
FDA: Weight Loss Drug Possibly Linked to Cancer
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Kegel Exercises After Prostate Surgery Called Into Question
Pelvic physical therapy may be more appropriate than Kegel exercises in managing post-radical prostatectomy pain and stress urinary incontinence, according to a new study.
Splenomegaly May Be a Negative Prognostic Factor in Essential Thrombocythemia and Polycythemia Vera
Currently, splenomegaly is not included as a prognostic factor in major prognostic models of Philadelphia-negative myeloproliferative neoplasms.
AI System Can Detect, Grade Cancer in Prostate Needle Biopsy
AUCs were 0.997, 0.986 for distinguishing between benign, malignant biopsy cores, respectively.
Cancer Incidence Up in World Trade Center Responder Cohort
Incidence up for all cancer sites combined and for prostate cancer, thyroid cancer, leukemia.
Bladder Cancer Surgery Safe Following Neoadjuvant Immunotherapy
Toxicity profile and readmission rates among patients who underwent radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab are in line with previously published series reporting 90-day outcomes after RC with or without neoadjuvant chemotherapy.
Ruxolitinib Plus PEG-IFNα2 for Patients With Polycythemia Vera or Myelofibrosis
The study’s primary endpoint was efficacy, determined by complete remission, peripheral blood cell count remission, quality of life, and JAK2 V617F allele burden.
Avatrombopag Designated Orphan Drug for Chemo-Induced Thrombocytopenia
The FDA has granted Orphan Drug designation to avatrombopag for the potential treatment of chemotherapy-induced thrombocytopenia, a complication that may lead to chemotherapy dose delays and regimen changes.
Skin Cancer Clinical Trials
Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy
Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy
Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC
Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC
Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Want to read more?
Please login or register first to view this content.
Next post in Daily Oncology News
